Search - tctmd.com

Displaying 141 - 160 of 191

Sort: Relevancy | Date

Presentation TCT 2014

PCI vs CABG: Surgery for Most!

Presenter: Alejandro Cherro, Liliana R. Grinfeld, Michael E. Farkouh

September 13, 2014

News Daily News

联合血运重建有望给糖尿病患者带来福音

L.A. McKeown

July 24, 2014

News Daily News

Hybrid Revascularization a Promising Option for Diabetic Patients

L.A. McKeown

July 24, 2014

News Daily News

Una Estrategia con Trimetazidina Reduce la NIC y la Lesión Miocárdica en Pacientes Diabéticos con ERC de Carácter entre Leve y Moderado

May 30, 2014

News Daily News

Pre-PCI Trimetazidine Strategy Reduces CIN, Myocardial Injury in Diabetic Patients with Mild-to-Moderate CKD

May 30, 2014

Presentation

Trimetazidine Impacts on Myocardial Injury and CIN in Diabetic Patients with RD Undergoing Elective PCI

Presenter: Mohamed A. Shehata

May 27, 2014

News Daily News

El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición

L.A. McKeown

April 11, 2014

News Daily News

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

L.A. McKeown

April 11, 2014

Presentation PCI Outcomes 2014

Perspectives on PCI vs CABG in the Diabetic Patient: The FREEDOM to Disagree with FREEDOM

Presenter: Gregg W. Stone

March 28, 2014

News Daily News

Los Resultados SLF Varían según el Estado de la Diabetes y la Complejidad de la Lesión

Caitlin E. Cox

March 13, 2014

News Daily News

DES Outcomes Vary by Diabetes Status, Lesion Complexity

Caitlin E. Cox

March 13, 2014

Presentation TCT 2013

The Glucometabolic Milieu: Implications on Platelet Function in the PCI Patient

Presenter: Frederick Feit

October 30, 2013

Presentation TCT 2013

The Effect of Tight Metabolic Control in Diabetic Patients Undergoing PCI

Presenter: Marco Wainstein

October 30, 2013

Presentation TCT 2013

Diabetes Mellitus and Multivessel Disease: Not so Fast, PCI for Many!

Presenter: Kevin Beatt

October 30, 2013

Presentation

Quality of Life after PCI vs. CABG Among Patients with Diabetes and Multivessel CAD

Presenter: M.S. Abdallah

October 15, 2013

News Daily News

Early QOL Advantage of CABG Over PCI for Diabetic Patients Disappears After 2 Years

L.A. McKeown

October 15, 2013

News Daily News

高风险亚组从瑞舒伐他汀中获得肾脏保护

Caitlin E. Cox

October 11, 2013

News Daily News

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

Caitlin E. Cox

October 11, 2013

News Daily News

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Caitlin E. Cox

October 11, 2013

News Daily News

Meta-analysis Confirms Mortality Edge with CABG over PCI in Diabetic Patients

L.A. McKeown

September 20, 2013

Advertisement

PCI vs CABG: Surgery for Most!

联合血运重建有望给糖尿病患者带来福音

Hybrid Revascularization a Promising Option for Diabetic Patients

Una Estrategia con Trimetazidina Reduce la NIC y la Lesión Miocárdica en Pacientes Diabéticos con ERC de Carácter entre Leve y Moderado

Pre-PCI Trimetazidine Strategy Reduces CIN, Myocardial Injury in Diabetic Patients with Mild-to-Moderate CKD

Trimetazidine Impacts on Myocardial Injury and CIN in Diabetic Patients with RD Undergoing Elective PCI

El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

Perspectives on PCI vs CABG in the Diabetic Patient: The FREEDOM to Disagree with FREEDOM

Los Resultados SLF Varían según el Estado de la Diabetes y la Complejidad de la Lesión

DES Outcomes Vary by Diabetes Status, Lesion Complexity

The Glucometabolic Milieu: Implications on Platelet Function in the PCI Patient

The Effect of Tight Metabolic Control in Diabetic Patients Undergoing PCI

Diabetes Mellitus and Multivessel Disease: Not so Fast, PCI for Many!

Quality of Life after PCI vs. CABG Among Patients with Diabetes and Multivessel CAD

Early QOL Advantage of CABG Over PCI for Diabetic Patients Disappears After 2 Years

高风险亚组从瑞舒伐他汀中获得肾脏保护

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Meta-analysis Confirms Mortality Edge with CABG over PCI in Diabetic Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content